Athletic injuries don’t always mean surgery anymore. Stem cell therapy, PRP, PRGF, BMAC, microfragmented adipose, donor MSCs, Wharton’s jelly, exosomes — the regenerative toolkit is broader than most athletes (or their physicians) realize. Each option fits a different injury and a different patient. What follows is the working map.
Why athletes use regenerative medicine
Regenerative medicine supports the body’s repair processes as a targeted alternative to surgery and chronic pain management. Athletes use it for:
- Ligament and tendon injuries
- Cartilage damage
- Chronic pain conditions
The benefit profile: reduce inflammation, accelerate tissue repair, return to play faster than a surgical timeline.
The treatment toolkit
Stem cell therapy
Stem cells and related products are harvested from bone marrow, umbilical tissue, adipose, or other sources, and injected into the injured area. Some clinics use orthobiologics from donor tissue or lab-cultivated lines in place of autologous cells.
Common indications: ACL repair surgery and recovery, cartilage regeneration, rotator cuff tears, tendon repair.
Regulatory status. In the U.S. the FDA classifies products as minimally manipulated (Section 361 — centrifugation, retains natural characteristics, lower oversight) or substantially manipulated (Section 351 — techniques like enzymatic digestion, stricter regulation). As of 2025 SVF and other significantly processed stem cell therapies are classified as drugs and subject to strict FDA regulation. The EMA in Europe applies similar ATMP standards.
The regenerative therapies, defined
- Platelet-Rich Plasma (PRP) — your blood, minimally processed, used to reduce inflammation and promote healing in tendons and ligaments.
- Platelet-Rich Fibrin (PRF) — a next-generation PRP using a slower spin, retaining more growth factors. Thicker, gel-like consistency, useful for complex repairs. Sometimes used cosmetically under brand names like “EZ Gel” (e.g., under-eye work).
- Plasma Rich in Growth Factors (PRGF) — more advanced preparation isolating specific growth factors, used in complex repairs by providers like Dr. Ramon Cugat at Instituto Cugat in Spain.
- Muse Cells (Multi-lineage Differentiating Stress Enduring Cells) — a stem cell type found in your own fat or bone marrow, under research for advanced healing.
- Umbilical Cord Cells and Wharton’s Jelly — collected at birth, rich in mesenchymal stem cells (MSCs). Different lines have different risk profiles, still under evaluation. Handling, preparation, and ethical sourcing all matter.
- Donor MSCs — donor-derived stem cells processed for FDA/EMA compliance. Same caveats around handling, preparation, and risk.
For more on ethics and safety, read here.
Platelet-Rich Plasma (PRP) in detail
PRP isolates platelets and growth factors from the patient’s blood and concentrates them for injection. Advanced preparations (PRGF, PRF) extend the toolkit into more complex repairs and cosmetic applications.
Dr. Rowan Paul, a leader in sports medicine and regenerative therapies, used PRP to treat my foot pain (he handles foot cases for San Francisco Ballet) and several other hEDS-related injuries. His participation in cutting-edge clinical trials gave me access to innovative therapies first-hand and meaningfully improved my recovery outcomes.
Dr. Ramon Cugat at Instituto Cugat in Spain used PRGF to repair my rotator cuff tear. The recovery was swift — I was back in the gym pain-free many months ahead of traditional surgical timelines.
Common indications: tennis elbow, rotator cuff, ligament strains.
Operator note: post-injection inflammation is expected and often indicates the regenerative process is engaging. Skilled injectors (Paul, Cugat) have detailed protocols around this that meaningfully affect outcomes.
Exosome therapy
Exosomes are extracellular vesicles that facilitate cell-to-cell communication, delivering proteins and growth factors to damaged tissues. Indications under study: tendon injuries, ligament damage, chronic pain, rejuvenation. Early benefits: reduced inflammation, precise tissue healing, minimal downtime.
Regulatory status. As of January 2025 the FDA has not approved exosome products for therapeutic use. Verify the source and safety of any product before treatment.
Where the field is going
- Stem cells. Advances in cell harvesting and cultivation are improving outcomes for cartilage, tendon, and ACL recovery.
- Exosomes. Strong safety profile and accessibility should drive mainstream use for ligament/tendon repair and regenerative cosmetics, with minimal disruption to training schedules.
- PRP. Likely to expand into chronic-condition management, faster-recovery protocols, and proactive injury prevention.
For the broader regulatory framework, the FDA has published four final guidance documents for human cells, tissues, and cellular and tissue-based products (HCT/Ps).
The micro-step mindset
The athletes and patients with the best outcomes treat recovery as a series of small, early interventions rather than waiting for a problem to escalate. PRP, stem cells, and exosomes used quickly after injury maximize the regenerative response. Coaches and support staff can monitor progress against clear protocols and catch setbacks early.
Regenerative medicine isn’t a replacement for surgery in every case — it’s a bridge between traditional reconstruction and sustainable performance. Used correctly, on the right indication, it shortens recovery and reduces the risk of reinjury. For the underlying differences between cellular products, see exosome vs. stem cell therapy.